Posttraumatic Stress Disorders Clinical Trial
Official title:
Examining Potential Moderators and Mediators in the Expressive Writing Intervention: The Role of Affect Regulation and Self-presentation.
Verified date | April 2010 |
Source | University of Toronto |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
The purpose of the present study is twofold. First, we will attempt to examine the role that
emotion regulation and self-presentation play as potential moderators in the expressive
writing paradigm. We hypothesize that expressive writing participants who demonstrate
greater abilities to regulate their emotions at baseline will improve more on our outcome
measures. We also hypothesize that those expressive writing participants who demonstrate
higher levels of self-presentation at baseline will improve less on our outcome measures.
The second aim of the study has two related objectives. First, we will attempt to
investigate whether the expressive writing intervention can increase and enhance an
individual's emotion regulation abilities. Related to this, we will then go on to examine
whether emotion regulation can be looked at as a potential mechanism of action in the
expressive writing procedure. Related to these two objectives, we hypothesize that in
comparison to the control group, participants in the expressive writing condition will show
increases in their ability to regulate their emotions from baseline to four week follow up.
Moreover, we predict that greater gains in emotion regulation abilities for the expressive
writing participants will be significantly related to greater gains in outcome measures.
Status | Active, not recruiting |
Enrollment | 90 |
Est. completion date | February 2010 |
Est. primary completion date | December 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Fluent in English - Previously experienced trauma (not current or ongoing; excluding bereavement) - Currently experiencing trauma-related distress Exclusion Criteria: - Currently involved in psychotherapy - Currently taking psychotropic medications - Imminent threat to self or others |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | Ontario Institute for Studies in Education of the University of Toronto | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
University of Toronto |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Posttraumatic Stress Diagnostic Scale | Initial session; One month follow-up | No | |
Secondary | Difficulties in Emotion Regulation Scale | Initial session; One month follow-up | No | |
Secondary | Pennebaker Inventory of Limbic Languidness | Initial session; One month follow-up | No | |
Secondary | Beck Depression Inventory, Second Edition | Initial session; One month follow-up | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00611871 -
The Use of Propranolol to Block Memory Reconsolidation in PTSD
|
Phase 2 | |
Completed |
NCT02057081 -
Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI
|
N/A | |
Completed |
NCT03684473 -
An Online CBT, Mindfulness Meditation & Yoga (CBT-MY) Intervention for Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT00965809 -
Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)
|
Phase 4 | |
Unknown status |
NCT01033708 -
A Randomized Control Trial of Narrative Exposure Therapy Versus Treatment as Usual in the Therapy of Borderline Personality Disorder
|
N/A | |
Completed |
NCT02774642 -
Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)
|
N/A | |
Completed |
NCT01049516 -
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel
|
N/A | |
Completed |
NCT00105885 -
Telephone Care as a Substitute for Routine Psychiatric Medication
|
N/A | |
Completed |
NCT02556645 -
A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel
|
N/A | |
Recruiting |
NCT01743664 -
The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis
|
Phase 3 | |
Completed |
NCT01158001 -
Telemedicine for Improved Delivery of Psychosocial Treatments for Post Traumatic Stress Disorder
|
N/A | |
Completed |
NCT03997344 -
Veterans Nature Therapy (Vet Hike)
|
N/A | |
Completed |
NCT01605253 -
Eszopiclone for the Treatment of Posttraumatic Stress Disorder
|
Phase 4 | |
Not yet recruiting |
NCT02384369 -
Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder
|
Phase 2 | |
Enrolling by invitation |
NCT02757339 -
Evaluating the Neurobiological Basis of Traumatic Dissociation in Women With Histories of Abuse and Neglect
|
||
Active, not recruiting |
NCT01157416 -
Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth
|
Phase 2 | |
Completed |
NCT01208844 -
Study of Physical Health for Women With Posttraumatic Stress or Depression
|
N/A | |
Not yet recruiting |
NCT01914861 -
Cortisol Diurnal Variation and the Risk for Developing Post Traumatic Stress Disorder
|
N/A | |
Unknown status |
NCT01644851 -
Cognitive Training for Post Traumatic Stress Disorder: Effects on Cognitive, Emotional, and Brain Function
|
N/A | |
Completed |
NCT01896388 -
Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial
|
Phase 1/Phase 2 |